Year | Le-vel | Student(s) | Title | External collaborator |
2024 | M | Mahnaz Mohammadzamani | Modelling response times from achievement tests | |
2023 | M | Stylianos Sidiropoulos | Forecasting airline revenue across markets with machine learning | Acceleration Nordic |
2020 | M | Ganna Fagerberg | Random-effects meta-analyses of observational studiesof rare events: comparing frequentist and Bayesian approaches | |
2020 | M | Martin Hyllienmark | Identifying minimax designs for clinical trials with a modified nested particle swarm optimization algorithm | |
2019 | M | Tobias Löv | Optimizing marketing campagins with active machine learning | |
2018 | M | Charlotte Pettersson | Using Supervised Learning to Predict COPD Exacerbations | IQVIA |
2017 | B | Johan Persson* | Restricted Region Exact Designs | |
2016 | M | Moa Thyni | Comparison of the pooled test with other multiple test procedures in clinical trials | |
2016 | M | Vasileios Manikas | A Bayesian Finite Mixture Model for Network-Telecommunication Data | Ericsson |
2016 | B | Hanna Pettersson | Workplace fatalities | |
2016 | B | Merrisha Axelsson & Edvard Åberg | Non-response analysis of non-response bias in Swedish Work Environment Investigation 2015 | Arbetsmiljö-verket |
2015 | B | Charlotta Löf Ryk & Anna Yang | Statistical methods for evaluating risk factors for urinary bladder cancer patients | |
2015 | B | Britt-Inger Forsberg & Yuliya Leontyeva | Multiple comparisons - in search for significance | |
2015 | B | Olli-Pekka Kinnunen & Karl Röcklinger | Extreme Car Insurance Claims and Their Seasonality | Insurance company |
2015 | M | Aaron Levine | Using Markov Models to Analyze Brand Switching Between Treatments of Chronic Respiratory Diseases | IMS Health |
2015 | M | Tommy Löfgren | Measuring survey mode effects using the principal stratification framework | |
2013 | B | Laszlo Sipos & Selma Aydin | Comparison of analysis models of effect of treatment for preterm infants | Sobi |
2010 | B | Carolina Blomqvist** | Response adaptive optimal design in clinical trials - a simulation study motivated by a real data example | AstraZeneca |